Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer

This study has been withdrawn prior to enrollment.
(no paticipants enrolled)
Sponsor:
Information provided by (Responsible Party):
Biotech Pharmaceutical Co., Ltd.
ClinicalTrials.gov Identifier:
NCT00985998
First received: September 27, 2009
Last updated: August 18, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: August 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)